Could biologic injectables change the eczema trajectory?

Could biologic injectables change the eczema trajectory?

From Eczema Breakthroughs by Global Parents for Eczema Research (GPER)

February 19, 2025 · 21 min · Episode 45

About this episode

The episode discusses the potential of biologic injectables in altering the eczema trajectory in children.

Could injectable drugs called "biologics" stop eczema by teaching a child's developing immune system to be less reactive? Dr. Amy Paller from Northwestern University Chicago and Dr. Elaine Siegfried from Saint Louis University in Missouri discuss stopping or tapering biologics and what happens to the immune system when we are on them. If you like our podcast, please consider supporting it with a tax deductible donation . Research discussed Clinical remission and therapy-free remission in pediatric patients with moderate-to-severe atopic dermatitis treated with dupilumab Factors Associated with Remission of Eczema in Children Persistence of Mild to Moderate Atopic Dermatitis Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children

People in this episode

Guests: Dr. Amy Paller, Dr. Elaine Siegfried

Topics covered

  • biologics
  • eczema treatment
  • immune system
  • pediatric dermatology
  • atopic dermatitis

Keywords

  • biologics
  • eczema
  • immune system
  • dupilumab
  • atopic dermatitis
  • pediatric patients
  • treatment

Mentioned in this episode

Organizations: Northwestern University Chicago, Saint Louis University

Products: dupilumab

More episodes of Eczema Breakthroughs

Explore listener stats, chart rankings, contacts and more on the Eczema Breakthroughs podcast page.